ROIV Articles, Roivant Sciences Ltd. - From 10/03/23

Allen Daniel Gold, Director at Roivant Sciences (NASDAQ:ROIV), reported a large insider sell on October 3, according to a new SEC filing. What Hap...

Keybanc cut the price target for Danaher Corporation (NYSE: DHR) from $325 to $300. Keybanc analyst Paul Knight maintained an Overweight rating....

Stocks are deep in the red during midday trading on Tuesday, with September proving to be a negative month for Wall Street, as has traditionally be...

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withd...

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s sessio...

Immunovant Inc (NASDAQ: IMVT), a unit of Roivant Sciences Ltd (NASDAQ: ROIV), announced that subcutaneously administered doses of IM...

Rakhi Kumar, Chief Accounting Officer at Roivant Sciences (NASDAQ:ROIV), reported a large exercise of company stock options on September 8, accordi...

Eric Venker, Chief Operating Officer at Roivant Sciences (NASDAQ:ROIV), reported a large exercise of company stock options on September 7, accordin...

Republican presidential primary candidate Vivek Ramaswamy is making all the right noises and has appealed to people with his rank-outsider status a...